Recent News

Share
Upcoming Seminars and Events

View upcoming seminars and events.

Learn more
541 News Items found
Profile
MSK PhD graduate Renhe Luo
2024 GSK Chairman’s Prize Recognizes Renhe Luo for Research on Gene Enhancers

Read about the research of Renhe Luo, winner of the 2024 GSK Chairman’s Prize, who studies gene enhancers.
An MSK scientists works in the lab
MSK Research Highlights, August 13, 2024

New MSK research found patients with non-small cell lung cancer brain metastases may benefit from up-front stereotactic radiosurgery; identified a connection between antibiotic use and autoimmune diseases; and uncovered a previously unknown structural role for messenger RNAs in the cytoplasm of cells.
MSK lab coat
MSK Researchers Discover Source of Deadly Fungal Infections in Bone Marrow Transplant Patients, New Study Finds

A team of researchers led by Memorial Sloan Kettering Cancer Center (MSK) and collaborators at Emory University are shedding new light on deadly fungal infections that develop in bone marrow transplant patients.
MSK Awards & Appointments January 2023
MSK Awards and Appointments June & July 2024

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
Andrea Schietinger
Better Together: Spatial Arrangement of Three Immune Cells Is Key to Attacking Tumors

In order for immune cells to effectively kill cancer cells, a triad of three cells are necessary — a dendritic cell, a cytotoxic “killer” T cell, and a helper T cell, researchers at MSK and Baylor College of Medicine have found. The discovery could alter the way doctors administer immunotherapies.
Ellen Horste
From Basic Science to Biotech: One MSK Alum’s Journey

Learn how GSK graduate Dr. Ellen Horste’s time investigating fundamental biological questions prepared her for a career in the emerging field of gene therapy.
Pancreatic cancer cells
MSK Discovery Suggests Opportunity to Improve Effectiveness of KRAS Inhibitors Against Pancreatic Cancer

MSK researchers have discovered a new mechanism of resistance to KRAS inhibitors that suggests an opportunity to make the treatment more effective.
detail shot of specimen slides
MSK Research Highlights, July 8, 2024

New MSK research developed a deep-learning model designed to aid challenging cancer diagnoses; identified key regulators of infection-clearing immune cells; and shed new light on the mechanical forces exerted by immune cells.
A researcher pipettes in the lab
MSK Research Highlights, June 25, 2024

New MSK research helped develop a machine-learning tool to help find cancer cells that remain after surgery; led to FDA approval for CAR T cell therapy against mantle cell lymphoma; tested a liquid biopsy approach that shows promise in detecting lung cancer; found checkpoint inhibitors were effective against endometrial and ovarian cancers with DNA-repair deficiency; and shed new light on mTOR's role in metabolic enzyme degradation.
Joseph Sun and Rebecca Delconte
Fasting Primes the Immune System’s Natural Killer Cells to Better Fight Cancer, New Study in Mice Finds

Animal model research from MSK has shown for the first time that fasting can reprogram the metabolism of natural killer cells, helping them to survive in the harsh environment in and around tumors, while also improving their cancer-fighting ability.